Sindrome poliglandular autoinmune tipo II en el Hospital Universitario del Caribe, Cartagena, Colombia.
Autoimmune polyglandular syndrome type II in Hospital Universitario del Caribe, Cartagena Colombia.
Barra lateral del artículo
PDF
FLIP
Contenido principal del artículo
Resumen
El Síndrome Poliglandular Autoinmune es una poliendocrinopatía caracterizada por falla de algunas glándulas endocrinas, así como también en órganos no endocrinos, originada por acciones del sistema inmune sobre tejidos endocrinos. Se han descrito dos grandes grupos y al menos dos o tres variantes de ellos. El Síndrome Poliglandular Autoinmune tipo II es la más común de las inmunoendocrinopatias. Se caracteriza por la presencia de la enfermedad de Addison en combinación con enfermedad tiroidea autoinmune y/o diabetes mellitus tipo I. Se realizo una revisión del tema con bases inmunogenéticas y etiopatológicas. Se presenta una serie de casos. La incidencia acumulada es de 1.2/100.000 habitante. El hallazgo más frecuente fue enfermedad de Addison más Tiroiditis autoinmune, (80 %) y la segunda asociación más frecuente fue tiroiditis con anemia perniciosa (60 %). Es importante resaltar la alta frecuencia de déficit de vitamina B12 en pacientes con severo compromiso neuronal. Pueden transcurrir hasta veinte años desde el diagnóstico de una endocrinopatía y la aparición de otra acompañante. Es deber realizar análisis diagnósticos para evaluar funciones hormonales correlacionadas con una endocrinopatia hasta la senescencia.
Palabras clave:
Descargas
Detalles del artículo
Referencias (VER)
Baker JR. 1997 Autoimmune endocrine disease. JAMA 278:1931–1937
Eisenbarth GS, Gottlieb PA. Autoimmune polyendocrine syndromes. N Engl J Med. May 13 2004;350(20):2068-79.
Addison T. Anemia: disease of the suprarenal capsules. Lond Med Gaz 1849;12:535–46.
Claude H, Gourgerot H. Insufficance, pluriglandulaire, endocrinienne. J Physiol Pathol Gen 1908;10:469–80.
Parkinson J. A case of pernicious anemia terminating in acute diabetes. Lancet 1910;2:543–6.
Hashimoto H. Zur kenntnis der lymphomatosen veranderung der schilddruse (struma lymphomatosa) Acta Klin Chir 1912; 97:219–48.
Schmidt MB. Eine biglandulare Erkrankung (Nebennieren und Schilddrusse) bei Morbus Addisonii. Verh Dtsch Ges Pathol Ges 1926;21:212–21.
Roitt I, Doniach D, Campbell PN, Hudson RV. Autoantibodies in Hashimoto’s disease (lymphadenoid goitre). Lancet 1956;2:820–1.
Carpenter CCJ, Solomon N, Silverberg SG, Bledsoe T, Northcutt RC, Klihenberg JR, et al. Schmidt’s syndrome (thyroid and adrenal insufficiency): A review of the literature and a report of fifteen new cases including ten instances of coexistent diabetes mellitus. Med 1964;43:153–80.
Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandual syndromes. Pediatr Ann 1980;9:154–62.
Maclaren N , Riley W. Thyroid, gastric and adrenal autoimmunities and insulin dependent diabetes. Diabetes Care (Suppl 1) 1985;8:34–8.
Dittmar M Kahaly G, Polyglandular Autoimmune Syndromes: Immunogenetics and Long-Term Follow-Up J Clin Endo Metab Vol. 88, No. 7 2983-2992. 2003.
Michels AW, Eisenbarth G Immunologic Endocrine Disorders J Allergy Clin Immunol. 2010 February ; 125(2 Suppl 2): S226–S237.
Muir A, She JX 1999 Advances in the genetics and immunology of autoimmune polyglandular syndrome II/III and their clinical applications. Ann Med Interne (Paris) 150:301–312
Bardwick P. A, Zvaifler N.J, Gill GN et al. Plasma cell dyscrasia with polyneuropathy,organomegaly, endocrinopathy, M protein and skin changes. The POEMS síndrome, Medicine 1980;58, 311-322.
Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, Dagna-Bricarelli F, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest 2006 June; 116(6):1713–22
Le BS, Geha RS. IPEX and the role of Foxp3 in the development and function of human Tregs. J Clin Invest 2006 June;116(6):1473–5.
Aaron M, and Eisenbarth G. Immunologic Endocrine Disorders. J Allergy Clin Immunol. 2010 February ; 125(2 Suppl 2): S226–S237
Departamento Admistrativo Nacional de Estadística (DANE). Censo General de 2005. Libro censo general. 2006. (1) 35.
Ten S, New M, MacLaren N 2001 Clinical review 130: Addison’s disease. J Clin Endocrinol Metab 86:2909–2922.
Laureti S, Vecchi L, et al. Is the prevalence of Addison disease underestimated? J Clin Endocrinol Metab 1999;84(5):1762.
Falorni A, Laureti S, et al. Autoantibodies in autoimmune polyendocrine syndrometype II. Endocrinol Metab Clin North Am 2002;31(2):369–89.
Neufeld M, Maclaren NK, et al. Two types of auto-immune Addison’s disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 1981;60(5):355–62.
Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmunepolyendocrine syndromes: autoantibodies, autoantigens, and their applicabilityin diagnosis and disease prediction. Endocr Rev 2002;23(3):327–64.
Betterle C, Lazzarotto F. Autoimmune polyglandular syndrome type 2: the tip of an iceberg? Clin Exp Immunol 2004;137(2):225–33.
Bakalov VK, Anasti JN, Calis KA, Vanderhoof VH, Premkumar A, Chen S, Furmaniak J, Smith BR,Merino MJ, Nelson LM. Autoimmune oophoritis as a mechanism of follicular dysfunction in womenwith 46, XX spontaneous premature ovarian failure. Fertil Steril 2005 October;84(4):958–65.
Schatz DA, Winter WE. Autoimmune polyglandular syndrome II: clinical síndrome and treatment. Endocrinol Metab Clin North Am 2002;31(2):339–52.
Owen CJ, Cheetham T. Diagnosis and management of polyendocrinopathy syndrome.Endocrinol Metab Clin N Am 38 (2009) 419–436.
Marrack P, Kappler J, Kotzin BL 2001 Autoimmune disease: why and where it occurs. Nat Med 7:899–905.
Otto E, Ochs K, Hansen C, Wall J, Kahaly G. Orbital tissue-derived T lymphocytes from patients with Graves’ ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab 81:3045–3050.
Muir A, She JX. Advances in the genetics and immunology of autoimmune polyglandular syndrome II/III and their clinical applications. Ann Med Interne (Paris) 150:301–312.
Kriegel M, Lohmann T, Gabler C, Blank N, Kalden JR,and Lorenz H-M. Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II. J. Exp. Med.Volume 199, Number 9, May 3, 2004 1285–1291.
Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH 2001 Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294
Eisenbarth G, Wilson P, Ward F, Lebovita H 1978 HLA type and occurrence of disease in familial polyglandular failure. N Engl J Med 298:92–94
Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80:2112
Badenhoop K, Walfish PG, Rau H, Fischer S, Nicolay A, Bogner U. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 80:2112–2117
Huang W, Connor E, Rosa TD, Muir A, Schatz D, Silverstein J, Crockett S, She JX, Maclaren NK 1996 Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in ß-cell autoimmunity. J Clin Endocrinol Metab 81:2559–2563.
Eisenbarth GS, Wilson PW, Ward F, Buckley C, Lebovita H. The polyglandular failure syndrome: disease inheritance, HLA type, and immune function. Ann Intern Med 91:528–533.
Ghanny S, Wallerstein R, Chartoff A, Post J, Aisenberg J, Auyeung V.Six year old with autoimmune polyglandular syndrome: can genetics tell us the story? J Pediatr Endocrinol Metab. 2010 Jul;23(7):725-8.
Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997;84:223–43.
Molina Garrido M.J, Guillén Ponce C, Síndrome pluriglandular autoinmune. Revisión . An. Med. Interna (Madrid) v.24 n.9 Madrid sep. 2007.
